FIELD: pharmaceuticals.
SUBSTANCE: invention refers to compounds of formula (I):
,
where: ♦ Y is -NH- group or an oxygen atom; ♦ R1 is a linear or branched (C1-C6) alkyl group or a halogen atom; ♦ R2, R3 and R4 independently represent a hydrogen atom, a halogen atom or a linear or branched (C1-C6) alkyl group; ♦ R5 represents a hydrogen atom; ♦ R6 represents or
♦ R7 represents a hydrogen atom or a linear or branched (C1-C6)alkyl group; ♦ R8 is -O-P(O)(O−)(O−) group, -OP(O)(O−)(OR10) group, -OP(O)(OR10)(OR10') group, -O-SO2-O- group, -O-SO2-OR10 group, dioxolyl, -O-C(O)-R9 group, -O-C(O)-OR9 group or -OC(O)-NR9R9' group; ♦ R9 and R9' independently of each other represent a hydrogen atom, a linear or branched (C1-C6)alkyl group or a linear or branched amino (C1-C6)alkyl group; ♦ R10 and R10' each independently represent a hydrogen atom, a linear or branched (C1-C6)alkyl group or an aryl (C1-C6) group, it is possible that thus defined ammonium existed in zwitterion form or had a monovalent anionic counterion, which are inhibitors of Mcl-1, as well as to pharmaceutical compositions containing said compound, and use thereof.
EFFECT: disclosed are new ammonium derivatives, a method for preparing them and pharmaceutical compositions containing them.
28 cl, 1 tbl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL HYDROXY ACID DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2745430C1 |
NOVEL THIENO-PYRIMIDINE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2014 |
|
RU2605403C2 |
NOVEL HYDROXY-ESTER DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2734418C2 |
NOVEL AMINO ACID DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2747673C2 |
NEW BICYCLIC DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2760554C1 |
LIPOSOMAL DRUG FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASM | 2017 |
|
RU2756755C2 |
LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (KDM1A) INHIBITORS FOR DISEASE THERAPY | 2019 |
|
RU2813145C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
CERTAIN CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2014 |
|
RU2718876C2 |
1-(4-ISOXAZOLE-5-YL)-1H-PYRAZOLE-1-YL)-2-METHYLPROPANE-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATMENT OF AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION | 2018 |
|
RU2785342C2 |
Authors
Dates
2021-02-15—Published
2016-12-19—Filed